Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohns disease research.
CAS Number:
[219716-33-3]
Target:
Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted